Literature DB >> 14641860

Thirty-five years of Rh prophylaxis.

John Bowman1.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 14641860     DOI： 10.1111/j.0041-1132.2003.00632.x

Source DB:  PubMed          Journal:  Transfusion        ISSN： 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  21 in total

1.  Hemolytic disease of the newborn- anti c antibody induced hemolysis.

Authors:  Srinivas Murki; Hemasree Kandraju; Surekha A Devi
Journal:  Indian J Pediatr       Date:  2011-06-01       Impact factor: 1.967

2.  Improving the management and outcome in haemolytic disease of the foetus and newborn.

Authors:  Enrico Lopriore; Mirjam E A Rath; Helen Liley; Vivianne E H J Smits-Wintjens
Journal:  Blood Transfus       Date:  2013-07-19       Impact factor: 3.443

Review 3.  The role of antenatal immunoprophylaxis in the prevention of maternal-foetal anti-Rh(D) alloimmunisation.

Authors:  Giancarlo Maria Liumbruno; Angelo D'Alessandro; Federica Rea; Vanessa Piccinini; Liviana Catalano; Gabriele Calizzani; Simonetta Pupella; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2010-01       Impact factor: 3.443

4.  Recommendations for the prevention and treatment of haemolytic disease of the foetus and newborn.

Authors:  Francesco Bennardello; Serelina Coluzzi; Giuseppe Curciarello; Tullia Todros; Stefania Villa
Journal:  Blood Transfus       Date:  2015-01       Impact factor: 3.443

5.  2016 proceedings of the National Heart, Lung, and Blood Institute's scientific priorities in pediatric transfusion medicine.

Authors:  Pablo Cure; Melania Bembea; Stella Chou; Allan Doctor; Anne Eder; Jeanne Hendrickson; Cassandra D Josephson; Alan E Mast; William Savage; Martha Sola-Visner; Philip Spinella; Simon Stanworth; Marie Steiner; Traci Mondoro; Shimian Zou; Catherine Levy; Myron Waclawiw; Nahed El Kassar; Simone Glynn; Naomi L C Luban
Journal:  Transfusion       Date:  2017-03-28       Impact factor: 3.157

6.  A novel laboratory technique demonstrating the influences of RHD zygosity and the RhCcEe phenotype on erythrocyte D antigen expression.

Authors:  Patrick T McGann; Jenny M Despotovic; Thad A Howard; Russell E Ware
Journal:  Am J Hematol       Date:  2011-11-25       Impact factor: 10.047

7.  It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group.

Authors:  S Gerald Sandler; Willy A Flegel; Connie M Westhoff; Gregory A Denomme; Meghan Delaney; Margaret A Keller; Susan T Johnson; Louis Katz; John T Queenan; Ralph R Vassallo; Clayton D Simon
Journal:  Transfusion       Date:  2014-12-01       Impact factor: 3.157

8.  Financial implications of RHD genotyping of pregnant women with a serologic weak D phenotype.

Authors:  Seema Kacker; Ralph Vassallo; Margaret A Keller; Connie M Westhoff; Kevin D Frick; S Gerald Sandler; Aaron A R Tobian
Journal:  Transfusion       Date:  2015-03-21       Impact factor: 3.157

Review 9.  Chimerism in transfusion medicine: the grandmother effect revisited.

Authors:  Patricia A R Brunker
Journal:  Chimerism       Date:  2013-11-06

Review 10.  Approach to red blood cell antibody testing during pregnancy: Answers to commonly asked questions.

Authors:  Leigh Minuk; Gwen Clarke; Lani Lieberman
Journal:  Can Fam Physician       Date:  2020-07       Impact factor: 3.275
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.